Last 12 months
Inside the activity.
1 purchase rows · 62 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 1 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 30 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2022 Filed Jun 3, 2022 16:07 UTC |
Quane Alessandrea C.EVP, Chief Insurance Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004760 · primarydocument.xml · derivative · entry 3 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,204 Underlying: Class A Common Stock · 7,016 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021. F4 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 16:07 UTC |
Quane Alessandrea C.EVP, Chief Insurance Officer
|
Exercise / conversionClass A Common Stock | 7,016 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-004760 · primarydocument.xml · nonDerivative · entry 1 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:08 UTC |
Blackley Richard ScottChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004761 · primarydocument.xml · derivative · entry 3 Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,204 Underlying: Class A Common Stock · 7,016 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vests in sixteen equal quarterly installments beginning on December 1, 2021. F4 · derivative.expiration_date: The restricted stock units vests in sixteen equal quarterly installments beginning on December 1, 2021. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:08 UTC |
Blackley Richard ScottChief Financial Officer
|
Exercise / conversionClass A Common Stock | 7,016 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-004761 · primarydocument.xml · nonDerivative · entry 1 Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,488 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:09 UTC |
Bopitiya RanmaliEVP & Chief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 20,424 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004764 · primarydocument.xml · derivative · entry 3 Bopitiya Ranmali · CIK 0001908069 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,373 Underlying: Class A Common Stock · 20,424 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2022. F4 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2022. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:09 UTC |
Bopitiya RanmaliEVP & Chief Legal Officer
|
Exercise / conversionClass A Common Stock | 20,424 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-004764 · primarydocument.xml · nonDerivative · entry 1 Bopitiya Ranmali · CIK 0001908069 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:08 UTC |
Weaver DennisChief Clinical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004762 · primarydocument.xml · derivative · entry 5 Weaver Dennis · CIK 0001844219 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,834 Underlying: Class A Common Stock · 4,167 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest in sixteen equal quarterly installments beginning on June 1, 2021. F5 · derivative.expiration_date: The restricted stock units vest in sixteen equal quarterly installments beginning on June 1, 2021. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:08 UTC |
Weaver DennisChief Clinical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004762 · primarydocument.xml · derivative · entry 4 Weaver Dennis · CIK 0001844219 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,059 Underlying: Class A Common Stock · 2,004 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. F4 · derivative.expiration_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:08 UTC |
Weaver DennisChief Clinical Officer
|
Exercise / conversionClass A Common Stock | 4,167 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-004762 · primarydocument.xml · nonDerivative · entry 2 Weaver Dennis · CIK 0001844219 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,536 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:08 UTC |
Weaver DennisChief Clinical Officer
|
Exercise / conversionClass A Common Stock | 2,004 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-004762 · primarydocument.xml · nonDerivative · entry 1 Weaver Dennis · CIK 0001844219 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,369 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| April 15, 2022 Filed Apr 19, 2022 21:01 UTC |
PHILLIPS JR CHARLES EDirector
|
GrantDeferred Stock Unit · Derivative | 617 | $8.91 | $5,497.47 |
DisclosureSEC source: 0001562180-22-003470 · primarydocument.xml · derivative · entry 1 PHILLIPS JR CHARLES E · CIK 0001236185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 617 Underlying: Class A Common Stock · 617 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents a right to receive one share of the Company's Class A common stock. F2 · price: The Reporting Person elected, pursuant to the Issuer's Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A Common Stock on April 14, 2022, which price was used to calculate the number of deferred stock units issued to the Reporting Person. F3 · derivative.exercise_date: The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of cash retainer payment are 100% vested on the grant date. F3 · derivative.expiration_date: The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of cash retainer payment are 100% vested on the grant date. Read SEC document |
| April 15, 2022 Filed Apr 19, 2022 21:02 UTC |
BOYD JEFFERY HDirector
|
GrantDeferred Stock Unit · Derivative | 1,480 | $8.91 | $13,186.80 |
DisclosureSEC source: 0001562180-22-003471 · primarydocument.xml · derivative · entry 1 BOYD JEFFERY H · CIK 0001214606 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,480 Underlying: Class A Common Stock · 1,480 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents a right to receive one share of the Company's Class A common stock. F2 · price: The Reporting Person elected, pursuant to the Issuer's Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A Common Stock on April 14, 2022, which price was used to calculate the number of deferred stock units issued to the Reporting Person. F3 · derivative.exercise_date: The deferred stock units will be settled for cash or shares of Class A Common common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service (ii) a change in control (iii) death; or (iv) disability. Deferred stock units issued in lieu of cash retainer payment are 100% vested on the grant date. F3 · derivative.expiration_date: The deferred stock units will be settled for cash or shares of Class A Common common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service (ii) a change in control (iii) death; or (iv) disability. Deferred stock units issued in lieu of cash retainer payment are 100% vested on the grant date. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 16:35 UTC |
Quane Alessandrea C.EVP, Chief Insurance Officer
|
SaleClass A Common Stock | 11,638 | $8.30 | $96,595.40 |
DisclosureSEC source: 0001562180-22-002541 · primarydocument.xml · nonDerivative · entry 2 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,608 F2 · shares: The sale was effected to satisfy the Reporting Person's tax withholding obligation upon the settlement of previously granted equity awards. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 16:35 UTC |
Quane Alessandrea C.EVP, Chief Insurance Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002541 · primarydocument.xml · derivative · entry 3 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,750 Underlying: Class A Common Stock · 31,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter. F3 · derivative.expiration_date: The restricted stock units vest with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 16:35 UTC |
Quane Alessandrea C.EVP, Chief Insurance Officer
|
Exercise / conversionClass A Common Stock | 31,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-002541 · primarydocument.xml · nonDerivative · entry 1 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 22:42 UTC |
Blackley Richard ScottChief Financial Officer
|
SaleClass A Common Stock | 19,204 | $7.33 | $140,845.98 |
DisclosureSEC source: 0001562180-22-002490 · primarydocument.xml · nonDerivative · entry 2 Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,472 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.33 to $7.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 22:42 UTC |
Blackley Richard ScottChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002490 · primarydocument.xml · derivative · entry 3 Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 687,500 Underlying: Class A Common Stock · 62,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter. F4 · derivative.expiration_date: The restricted stock units vest with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 22:42 UTC |
Blackley Richard ScottChief Financial Officer
|
Exercise / conversionClass A Common Stock | 62,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-002490 · primarydocument.xml · nonDerivative · entry 1 Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 17:42 UTC |
Quane Alessandrea C.EVP, Chief Insurance Officer
|
SaleClass A Common Stock | 2,680 | $6.92 | $18,547.74 |
DisclosureSEC source: 0001562180-22-002312 · primarydocument.xml · nonDerivative · entry 2 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,996 F2 · shares: The sale was effected to satisfy the Reporting Person's tax withholding obligation upon the settlement of previously granted equity awards. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 22:42 UTC |
Blackley Richard ScottChief Financial Officer
|
SaleClass A Common Stock | 2,605 | $6.91 | $18,009.67 |
DisclosureSEC source: 0001562180-22-002311 · primarydocument.xml · nonDerivative · entry 2 Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,176 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 22:42 UTC |
Weaver DennisChief Clinical Officer
|
SaleClass A Common Stock | 1,890 | $6.94 | $13,117.17 |
DisclosureSEC source: 0001562180-22-002314 · primarydocument.xml · nonDerivative · entry 3 Weaver Dennis · CIK 0001844219 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,365 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 22:42 UTC |
Joyce Meghan V.Chief Operating Officer
|
SaleClass A Common Stock | 2,540 | $6.91 | $17,555.46 |
DisclosureSEC source: 0001562180-22-002313 · primarydocument.xml · nonDerivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,070 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9105 to $6.915, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 17:42 UTC |
Quane Alessandrea C.EVP, Chief Insurance Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002312 · primarydocument.xml · derivative · entry 3 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,220 Underlying: Class A Common Stock · 7,016 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021. F3 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 17:42 UTC |
Quane Alessandrea C.EVP, Chief Insurance Officer
|
Exercise / conversionClass A Common Stock | 7,016 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-002312 · primarydocument.xml · nonDerivative · entry 1 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:42 UTC |
Blackley Richard ScottChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002311 · primarydocument.xml · derivative · entry 3 Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,220 Underlying: Class A Common Stock · 7,016 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. F3 · derivative.expiration_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:42 UTC |
Blackley Richard ScottChief Financial Officer
|
Exercise / conversionClass A Common Stock | 7,016 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-002311 · primarydocument.xml · nonDerivative · entry 1 Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:42 UTC |
Weaver DennisChief Clinical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,005 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002314 · primarydocument.xml · derivative · entry 5 Weaver Dennis · CIK 0001844219 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,064 Underlying: Class A Common Stock · 2,005 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. F4 · derivative.expiration_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:42 UTC |
Weaver DennisChief Clinical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002314 · primarydocument.xml · derivative · entry 4 Weaver Dennis · CIK 0001844219 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,001 Underlying: Class A Common Stock · 4,166 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in sixteen equal quarterly installments beginning on June 1, 2021. F3 · derivative.expiration_date: The restricted stock units vest in sixteen equal quarterly installments beginning on June 1, 2021. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:42 UTC |
Weaver DennisChief Clinical Officer
|
Exercise / conversionClass A Common Stock | 4,166 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-002314 · primarydocument.xml · nonDerivative · entry 2 Weaver Dennis · CIK 0001844219 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:42 UTC |
Weaver DennisChief Clinical Officer
|
Exercise / conversionClass A Common Stock | 2,005 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-002314 · primarydocument.xml · nonDerivative · entry 1 Weaver Dennis · CIK 0001844219 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:42 UTC |
Joyce Meghan V.Chief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002313 · primarydocument.xml · derivative · entry 4 Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,220 Underlying: Class A Common Stock · 7,016 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. F4 · derivative.expiration_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:42 UTC |
Joyce Meghan V.Chief Operating Officer
|
Exercise / conversionClass A Common Stock | 7,016 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-002313 · primarydocument.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 18:58 UTC |
Quane Alessandrea C.EVP, Chief Insurance Officer
|
SaleClass A Common Stock | 49,355 | $7.18 | $354,280.06 |
DisclosureSEC source: 0001562180-22-001604 · primarydocument.xml · nonDerivative · entry 3 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,660 F2 · shares: The sale was effected to satisfy the Reporting Person's tax withholding obligation upon the settlement of previously granted equity awards. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.12 to $7.2250, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 18:58 UTC |
Quane Alessandrea C.EVP, Chief Insurance Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001604 · primarydocument.xml · derivative · entry 5 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,236 Underlying: Class A Common Stock · 7,015 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021. F5 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 18:58 UTC |
Quane Alessandrea C.EVP, Chief Insurance Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001604 · primarydocument.xml · derivative · entry 4 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,000 Underlying: Class A Common Stock · 125,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and vest with respect to the remaining shares in 12 equal quarterly installments thereafter. F4 · derivative.expiration_date: The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and vest with respect to the remaining shares in 12 equal quarterly installments thereafter. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 18:58 UTC |
Quane Alessandrea C.EVP, Chief Insurance Officer
|
Exercise / conversionClass A Common Stock | 7,015 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-001604 · primarydocument.xml · nonDerivative · entry 2 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 18:58 UTC |
Quane Alessandrea C.EVP, Chief Insurance Officer
|
Exercise / conversionClass A Common Stock | 125,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-001604 · primarydocument.xml · nonDerivative · entry 1 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| February 03, 2022 Filed Feb 7, 2022 16:05 UTC |
Thrive Partners VII Growth GP, LLCDirector · 10% owner
Thrive Capital Partners VII Growth, L.P.Director · 10% owner
Thrive Partners VII GP, LLCDirector · 10% owner
Claremount VII Associates, L.P.Director · 10% owner
|
Grant7.25% Convertible Senior Notes · Derivative | 417,000 | $417,000.00 Strike: $8.32 | $173,889,000,000.00 |
DisclosureSEC source: 0000899243-22-005007 · doc4.xml · derivative · entry 2 Thrive Partners VII Growth GP, LLC · CIK 0001877735 · Director · 10% owner Thrive Capital Partners VII Growth, L.P. · CIK 0001841736 · Director · 10% owner Thrive Partners VII GP, LLC · CIK 0001877733 · Director · 10% owner Claremount VII Associates, L.P. · CIK 0001841808 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Claremount VII Associates, L.P. Disclosed balance after: 417,000 Underlying: Class A Common Stock · 50,111 shares Expires not disclosed F1 · derivative.exercise_date: The 7.25% Convertible Senior Notes (the "Notes") are governed by an indenture (the "Indenture") between the Issuer and U.S. Bank National Association, as trustee (the "Trustee"). The Notes bear interest at a rate of 7.25% per annum, payable in cash, commencing on June 30, 2022. The Notes may be converted by the holder, subject to certain conditions, at an initial conversion price of approximately $8.32. Before August 31, 2031, holders of the Notes have the right to convert their Notes only upon the occurrence of certain events more fully described in the Indenture. From and after August 31, 2031, holders of the Notes may convert their Notes at any time at their election until the close of business on the second scheduled trading day immediately before the December 31, 2031 maturity date. Upon conversion, the Notes will be settled, at the Issuer's election, in shares of Class A Common Stock, cash, or a combination of cash and shares of Class A Common Stock, F2 · derivative.exercise_date: (Continued from Footnote 1) subject to certain exceptions, including the right of the holder to elect to settle the Notes by Physical Settlement (as defined in the Indenture) upon conversion pursuant to the terms of the Investment Agreement, dated January 27, 2022, between the Issuer and the purchasers of the Notes. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events. Holders of the Notes have the right to require the Issuer to repurchase all or some of their Notes for cash, subject to certain conditions. The Notes are also subject to redemption under certain circumstances and include customary provisions relating to the occurrence of "Events of Default" (as defined in the Indenture). The Notes have a stated maturity of December 31, 2031, subject to earlier conversion, redemption or repurchase in accordance with their terms. F1 · derivative.expiration_date: The 7.25% Convertible Senior Notes (the "Notes") are governed by an indenture (the "Indenture") between the Issuer and U.S. Bank National Association, as trustee (the "Trustee"). The Notes bear interest at a rate of 7.25% per annum, payable in cash, commencing on June 30, 2022. The Notes may be converted by the holder, subject to certain conditions, at an initial conversion price of approximately $8.32. Before August 31, 2031, holders of the Notes have the right to convert their Notes only upon the occurrence of certain events more fully described in the Indenture. From and after August 31, 2031, holders of the Notes may convert their Notes at any time at their election until the close of business on the second scheduled trading day immediately before the December 31, 2031 maturity date. Upon conversion, the Notes will be settled, at the Issuer's election, in shares of Class A Common Stock, cash, or a combination of cash and shares of Class A Common Stock, F2 · derivative.expiration_date: (Continued from Footnote 1) subject to certain exceptions, including the right of the holder to elect to settle the Notes by Physical Settlement (as defined in the Indenture) upon conversion pursuant to the terms of the Investment Agreement, dated January 27, 2022, between the Issuer and the purchasers of the Notes. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events. Holders of the Notes have the right to require the Issuer to repurchase all or some of their Notes for cash, subject to certain conditions. The Notes are also subject to redemption under certain circumstances and include customary provisions relating to the occurrence of "Events of Default" (as defined in the Indenture). The Notes have a stated maturity of December 31, 2031, subject to earlier conversion, redemption or repurchase in accordance with their terms. F4 · ownership.nature: Securities held directly by Claremount VII Associates, L.P. ("Claremount VII"). Thrive Partners VII GP, LLC ("Thrive Partners VII") is the general partner of Claremount VII. Joshua Kushner is the sole managing member of Thrive Partners VII and, in his capacity as managing member, has voting and investment power over the securities held by Claremount VII. Each of the foregoing entities and Mr. Kushner disclaim beneficial ownership of the shares held of record by Claremount VII except to the extent of their pecuniary interest therein. Read SEC document |
| February 03, 2022 Filed Feb 7, 2022 16:05 UTC |
Thrive Partners VII Growth GP, LLCDirector · 10% owner
Thrive Capital Partners VII Growth, L.P.Director · 10% owner
Thrive Partners VII GP, LLCDirector · 10% owner
Claremount VII Associates, L.P.Director · 10% owner
|
Grant7.25% Convertible Senior Notes · Derivative | 34,583,000 | $34,583,000.00 Strike: $8.32 | $1,195,983,889,000,000.00 |
DisclosureSEC source: 0000899243-22-005007 · doc4.xml · derivative · entry 1 Thrive Partners VII Growth GP, LLC · CIK 0001877735 · Director · 10% owner Thrive Capital Partners VII Growth, L.P. · CIK 0001841736 · Director · 10% owner Thrive Partners VII GP, LLC · CIK 0001877733 · Director · 10% owner Claremount VII Associates, L.P. · CIK 0001841808 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Thrive Capital Partners VII Growth, L.P. Disclosed balance after: 34,583,000 Underlying: Class A Common Stock · 4,155,911 shares Expires not disclosed F1 · derivative.exercise_date: The 7.25% Convertible Senior Notes (the "Notes") are governed by an indenture (the "Indenture") between the Issuer and U.S. Bank National Association, as trustee (the "Trustee"). The Notes bear interest at a rate of 7.25% per annum, payable in cash, commencing on June 30, 2022. The Notes may be converted by the holder, subject to certain conditions, at an initial conversion price of approximately $8.32. Before August 31, 2031, holders of the Notes have the right to convert their Notes only upon the occurrence of certain events more fully described in the Indenture. From and after August 31, 2031, holders of the Notes may convert their Notes at any time at their election until the close of business on the second scheduled trading day immediately before the December 31, 2031 maturity date. Upon conversion, the Notes will be settled, at the Issuer's election, in shares of Class A Common Stock, cash, or a combination of cash and shares of Class A Common Stock, F2 · derivative.exercise_date: (Continued from Footnote 1) subject to certain exceptions, including the right of the holder to elect to settle the Notes by Physical Settlement (as defined in the Indenture) upon conversion pursuant to the terms of the Investment Agreement, dated January 27, 2022, between the Issuer and the purchasers of the Notes. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events. Holders of the Notes have the right to require the Issuer to repurchase all or some of their Notes for cash, subject to certain conditions. The Notes are also subject to redemption under certain circumstances and include customary provisions relating to the occurrence of "Events of Default" (as defined in the Indenture). The Notes have a stated maturity of December 31, 2031, subject to earlier conversion, redemption or repurchase in accordance with their terms. F1 · derivative.expiration_date: The 7.25% Convertible Senior Notes (the "Notes") are governed by an indenture (the "Indenture") between the Issuer and U.S. Bank National Association, as trustee (the "Trustee"). The Notes bear interest at a rate of 7.25% per annum, payable in cash, commencing on June 30, 2022. The Notes may be converted by the holder, subject to certain conditions, at an initial conversion price of approximately $8.32. Before August 31, 2031, holders of the Notes have the right to convert their Notes only upon the occurrence of certain events more fully described in the Indenture. From and after August 31, 2031, holders of the Notes may convert their Notes at any time at their election until the close of business on the second scheduled trading day immediately before the December 31, 2031 maturity date. Upon conversion, the Notes will be settled, at the Issuer's election, in shares of Class A Common Stock, cash, or a combination of cash and shares of Class A Common Stock, F2 · derivative.expiration_date: (Continued from Footnote 1) subject to certain exceptions, including the right of the holder to elect to settle the Notes by Physical Settlement (as defined in the Indenture) upon conversion pursuant to the terms of the Investment Agreement, dated January 27, 2022, between the Issuer and the purchasers of the Notes. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events. Holders of the Notes have the right to require the Issuer to repurchase all or some of their Notes for cash, subject to certain conditions. The Notes are also subject to redemption under certain circumstances and include customary provisions relating to the occurrence of "Events of Default" (as defined in the Indenture). The Notes have a stated maturity of December 31, 2031, subject to earlier conversion, redemption or repurchase in accordance with their terms. F3 · ownership.nature: Securities held directly by Thrive Capital Partners VII Growth, L.P. ("Thrive VII Growth"). Thrive Partners VII Growth GP, LLC ("Thrive Partners VII Growth") is the general partner of Thrive VII Growth. Joshua Kushner is the sole managing member of Thrive Partners VII Growth and, in his capacity as managing member, has voting and investment power over the securities held by Thrive VII Growth. Each of the foregoing entities and Mr. Kushner disclaim beneficial ownership of the shares held of record by Thrive VII Growth except to the extent of their pecuniary interest therein. Read SEC document |
| February 03, 2022 Filed Feb 7, 2022 21:05 UTC |
Kushner JoshuaDirector · Co-Founder and Vice Chairman · 10% owner
|
Grant7.25% Convertible Senior Notes · Derivative | 417,000 | $417,000.00 Strike: $8.32 | $173,889,000,000.00 |
DisclosureSEC source: 0000899243-22-005008 · doc4.xml · derivative · entry 2 Kushner Joshua · CIK 0001844181 · Director · Co-Founder and Vice Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Claremount VII Associates, L.P. Disclosed balance after: 417,000 Underlying: Class A Common Stock · 50,111 shares Expires not disclosed F1 · derivative.exercise_date: The 7.25% Convertible Senior Notes (the "Notes") are governed by an indenture (the "Indenture") between the Issuer and U.S. Bank National Association, as trustee (the "Trustee"). The Notes bear interest at a rate of 7.25% per annum, payable in cash, commencing on June 30, 2022. The Notes may be converted by the holder, subject to certain conditions, at an initial conversion price of approximately $8.32. Before August 31, 2031, holders of the Notes have the right to convert their Notes only upon the occurrence of certain events more fully described in the Indenture. From and after August 31, 2031, holders of the Notes may convert their Notes at any time at their election until the close of business on the second scheduled trading day immediately before the December 31, 2031 maturity date. Upon conversion, the Notes will be settled, at the Issuer's election, in shares of Class A Common Stock, cash, or a combination of cash and shares of Class A Common Stock, F2 · derivative.exercise_date: (Continued from Footnote 1) subject to certain exceptions, including the right of the holder to elect to settle the Notes by Physical Settlement (as defined in the Indenture) upon conversion pursuant to the terms of the Investment Agreement, dated January 27, 2022, between the Issuer and the purchasers of the Notes. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events. Holders of the Notes have the right to require the Issuer to repurchase all or some of their Notes for cash, subject to certain conditions. The Notes are also subject to redemption under certain circumstances and include customary provisions relating to the occurrence of "Events of Default" (as defined in the Indenture). The Notes have a stated maturity of December 31, 2031, subject to earlier conversion, redemption or repurchase in accordance with their terms. F1 · derivative.expiration_date: The 7.25% Convertible Senior Notes (the "Notes") are governed by an indenture (the "Indenture") between the Issuer and U.S. Bank National Association, as trustee (the "Trustee"). The Notes bear interest at a rate of 7.25% per annum, payable in cash, commencing on June 30, 2022. The Notes may be converted by the holder, subject to certain conditions, at an initial conversion price of approximately $8.32. Before August 31, 2031, holders of the Notes have the right to convert their Notes only upon the occurrence of certain events more fully described in the Indenture. From and after August 31, 2031, holders of the Notes may convert their Notes at any time at their election until the close of business on the second scheduled trading day immediately before the December 31, 2031 maturity date. Upon conversion, the Notes will be settled, at the Issuer's election, in shares of Class A Common Stock, cash, or a combination of cash and shares of Class A Common Stock, F2 · derivative.expiration_date: (Continued from Footnote 1) subject to certain exceptions, including the right of the holder to elect to settle the Notes by Physical Settlement (as defined in the Indenture) upon conversion pursuant to the terms of the Investment Agreement, dated January 27, 2022, between the Issuer and the purchasers of the Notes. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events. Holders of the Notes have the right to require the Issuer to repurchase all or some of their Notes for cash, subject to certain conditions. The Notes are also subject to redemption under certain circumstances and include customary provisions relating to the occurrence of "Events of Default" (as defined in the Indenture). The Notes have a stated maturity of December 31, 2031, subject to earlier conversion, redemption or repurchase in accordance with their terms. F4 · ownership.nature: Securities held directly by Claremount VII Associates, L.P. ("Claremount VII"). Thrive Partners VII GP, LLC ("Thrive Partners VII") is the general partner of Claremount VII. Joshua Kushner is the sole managing member of Thrive Partners VII and, in his capacity as managing member, has voting and investment power over the securities held by Claremount VII. Each of the foregoing entities and Mr. Kushner disclaim beneficial ownership of the shares held of record by Claremount VII except to the extent of their pecuniary interest therein. Read SEC document |
| February 03, 2022 Filed Feb 7, 2022 21:05 UTC |
Kushner JoshuaDirector · Co-Founder and Vice Chairman · 10% owner
|
Grant7.25% Convertible Senior Notes · Derivative | 34,583,000 | $34,583,000.00 Strike: $8.32 | $1,195,983,889,000,000.00 |
DisclosureSEC source: 0000899243-22-005008 · doc4.xml · derivative · entry 1 Kushner Joshua · CIK 0001844181 · Director · Co-Founder and Vice Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Thrive Capital Partners VII Growth, L.P. Disclosed balance after: 34,583,000 Underlying: Class A Common Stock · 4,155,911 shares Expires not disclosed F1 · derivative.exercise_date: The 7.25% Convertible Senior Notes (the "Notes") are governed by an indenture (the "Indenture") between the Issuer and U.S. Bank National Association, as trustee (the "Trustee"). The Notes bear interest at a rate of 7.25% per annum, payable in cash, commencing on June 30, 2022. The Notes may be converted by the holder, subject to certain conditions, at an initial conversion price of approximately $8.32. Before August 31, 2031, holders of the Notes have the right to convert their Notes only upon the occurrence of certain events more fully described in the Indenture. From and after August 31, 2031, holders of the Notes may convert their Notes at any time at their election until the close of business on the second scheduled trading day immediately before the December 31, 2031 maturity date. Upon conversion, the Notes will be settled, at the Issuer's election, in shares of Class A Common Stock, cash, or a combination of cash and shares of Class A Common Stock, F2 · derivative.exercise_date: (Continued from Footnote 1) subject to certain exceptions, including the right of the holder to elect to settle the Notes by Physical Settlement (as defined in the Indenture) upon conversion pursuant to the terms of the Investment Agreement, dated January 27, 2022, between the Issuer and the purchasers of the Notes. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events. Holders of the Notes have the right to require the Issuer to repurchase all or some of their Notes for cash, subject to certain conditions. The Notes are also subject to redemption under certain circumstances and include customary provisions relating to the occurrence of "Events of Default" (as defined in the Indenture). The Notes have a stated maturity of December 31, 2031, subject to earlier conversion, redemption or repurchase in accordance with their terms. F1 · derivative.expiration_date: The 7.25% Convertible Senior Notes (the "Notes") are governed by an indenture (the "Indenture") between the Issuer and U.S. Bank National Association, as trustee (the "Trustee"). The Notes bear interest at a rate of 7.25% per annum, payable in cash, commencing on June 30, 2022. The Notes may be converted by the holder, subject to certain conditions, at an initial conversion price of approximately $8.32. Before August 31, 2031, holders of the Notes have the right to convert their Notes only upon the occurrence of certain events more fully described in the Indenture. From and after August 31, 2031, holders of the Notes may convert their Notes at any time at their election until the close of business on the second scheduled trading day immediately before the December 31, 2031 maturity date. Upon conversion, the Notes will be settled, at the Issuer's election, in shares of Class A Common Stock, cash, or a combination of cash and shares of Class A Common Stock, F2 · derivative.expiration_date: (Continued from Footnote 1) subject to certain exceptions, including the right of the holder to elect to settle the Notes by Physical Settlement (as defined in the Indenture) upon conversion pursuant to the terms of the Investment Agreement, dated January 27, 2022, between the Issuer and the purchasers of the Notes. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events. Holders of the Notes have the right to require the Issuer to repurchase all or some of their Notes for cash, subject to certain conditions. The Notes are also subject to redemption under certain circumstances and include customary provisions relating to the occurrence of "Events of Default" (as defined in the Indenture). The Notes have a stated maturity of December 31, 2031, subject to earlier conversion, redemption or repurchase in accordance with their terms. F3 · ownership.nature: Securities held directly by Thrive Capital Partners VII Growth, L.P. ("Thrive VII Growth"). Thrive Partners VII Growth GP, LLC ("Thrive Partners VII Growth") is the general partner of Thrive VII Growth. Joshua Kushner is the sole managing member of Thrive Partners VII Growth and, in his capacity as managing member, has voting and investment power over the securities held by Thrive VII Growth. Each of the foregoing entities and Mr. Kushner disclaim beneficial ownership of the shares held of record by Thrive VII Growth except to the extent of their pecuniary interest therein. Read SEC document |
| December 07, 2021 Filed Dec 7, 2021 22:16 UTC |
Blackley Richard ScottChief Financial Officer
|
SaleClass A Common Stock | 86,160 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-007538 · primarydocument.xml · nonDerivative · entry 2 Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,765 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.76 to $10.045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| December 05, 2021 Filed Dec 7, 2021 22:16 UTC |
Blackley Richard ScottChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-007538 · primarydocument.xml · derivative · entry 3 Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750,000 Underlying: Class A Common Stock · 250,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter. F4 · derivative.expiration_date: The restricted stock units vest with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter. Read SEC document |
| December 05, 2021 Filed Dec 7, 2021 22:16 UTC |
Blackley Richard ScottChief Financial Officer
|
Exercise / conversionClass A Common Stock | 250,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-007538 · primarydocument.xml · nonDerivative · entry 1 Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 22:10 UTC |
Blackley Richard ScottChief Financial Officer
|
SaleClass A Common Stock | 2,090 | $8.81 | $18,413.95 |
DisclosureSEC source: 0001562180-21-007448 · primarydocument.xml · nonDerivative · entry 2 Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,925 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the settlement of previously granted equity awards Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 22:11 UTC |
Weaver DennisChief Clinical Officer
|
SaleClass A Common Stock | 2,410 | $8.79 | $21,171.85 |
DisclosureSEC source: 0001562180-21-007450 · primarydocument.xml · nonDerivative · entry 3 Weaver Dennis · CIK 0001844219 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,084 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 22:11 UTC |
Joyce Meghan V.Chief Operating Officer
|
SaleClass A Common Stock | 3,090 | $8.75 | $27,037.50 |
DisclosureSEC source: 0001562180-21-007449 · primarydocument.xml · nonDerivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,594 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 22:10 UTC |
Blackley Richard ScottChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-007448 · primarydocument.xml · derivative · entry 3 Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,236 Underlying: Class A Common Stock · 7,015 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. F3 · derivative.expiration_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 22:10 UTC |
Blackley Richard ScottChief Financial Officer
|
Exercise / conversionClass A Common Stock | 7,015 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-007448 · primarydocument.xml · nonDerivative · entry 1 Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 22:11 UTC |
Weaver DennisChief Clinical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-007450 · primarydocument.xml · derivative · entry 5 Weaver Dennis · CIK 0001844219 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,068 Underlying: Class A Common Stock · 2,004 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. F4 · derivative.expiration_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.